Matters

  • Served as co-lead trial counsel in an International Trade Commission patent investigation related to combination therapies (pharmaceutical and medical device) for dermatology.
  • Developed and oversaw Biologics Price Competition and Innovation Act (BPCIA) patent dance and preliminary injunction strategy for originator product.
  • Oversaw Hatch-Waxman litigation and litigation preparation for Fortune 500 originator company.
  • Represented gene editing company in jury patent infringement trial, resulting winning verdicts on noninfringement and invalidity.
  • Directed European counsel in pan-European patent enforcement campaign on an originator’s leading small molecule drug, resulting in multiple injunctions.
  • Led and oversaw patent defense strategy for biosimilar products in European patent litigation.
  • Advised board of directors of molecular diagnostics company on litigation and licensing strategy.
  • Developed and oversaw BPCIA patent dance strategy for biosimilar.
  • Oversaw Supreme Court writ of certiorari application in Hatch-Waxman dispute.